[go: up one dir, main page]

AU8195091A - Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease - Google Patents

Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease

Info

Publication number
AU8195091A
AU8195091A AU81950/91A AU8195091A AU8195091A AU 8195091 A AU8195091 A AU 8195091A AU 81950/91 A AU81950/91 A AU 81950/91A AU 8195091 A AU8195091 A AU 8195091A AU 8195091 A AU8195091 A AU 8195091A
Authority
AU
Australia
Prior art keywords
ropinirole
domperidone
parkinson
medicament
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81950/91A
Inventor
Christian De Mey
Nadarajah Sree Haran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of AU8195091A publication Critical patent/AU8195091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU81950/91A 1990-07-09 1991-07-08 Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease Abandoned AU8195091A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9015095 1990-07-09
GB909015095A GB9015095D0 (en) 1990-07-09 1990-07-09 Therapeutic method

Publications (1)

Publication Number Publication Date
AU8195091A true AU8195091A (en) 1992-02-04

Family

ID=10678840

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81950/91A Abandoned AU8195091A (en) 1990-07-09 1991-07-08 Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease

Country Status (3)

Country Link
AU (1) AU8195091A (en)
GB (1) GB9015095D0 (en)
WO (1) WO1992000735A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07506823A (en) * 1992-05-18 1995-07-27 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
AR030557A1 (en) 2000-04-14 2003-08-27 Jagotec Ag A TABLET IN MULTI-MAP OF CONTROLLED RELEASE AND TREATMENT METHOD

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament

Also Published As

Publication number Publication date
WO1992000735A1 (en) 1992-01-23
GB9015095D0 (en) 1990-08-29

Similar Documents

Publication Publication Date Title
EP0333344A3 (en) Corneal implants and manufacture and use thereof
EP0331620A3 (en) Agent for the treatment of parkinson's disease
NZ270177A (en) Use of benzothiophene derivatives in the preparation of medicaments for inhibiting conditions associated with alzheimer's disease
CY2007001I2 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
AU7397094A (en) Prevention and treatment of alzheimer's disease
AU4048295A (en) Peptide medicaments for the treatment of disease
AU3279395A (en) Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
AU5127098A (en) Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
IL119894A (en) Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis
AU1197992A (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU4759390A (en) Method of medical treatment of alzheimer's disease
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
EP0676200A3 (en) Use of eliprodil and of its enantiomers in the preparation of medicaments for the treatment of peripheral neuropathies and or central neurodegenerative diseases.
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU2143488A (en) Use of a compound for the treatment of sleep disorders and depression
AU8195091A (en) Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
HUP9802929A3 (en) Use of allylamine derivatives in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
AU8185491A (en) Treatment of disease
EP0666745A4 (en) Diagnosis and therapy for parkinson's disease.
AU1807592A (en) New combination preparation for treatment of parkinson's disease
AU6491890A (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis
NZ268039A (en) Use of efaroxan in treating parkinson's disease